Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F
- PMID: 21226626
- DOI: 10.1089/AID.2010.0177
Construction and phenotypic characterization of HIV type 1 functional envelope clones of subtypes G and F
Abstract
Subtype G has been estimated to represent the fourth most prevalent clade in the HIV-1 pandemic and subtype F is widely circulating in parts of South America (frequently within BF recombinant forms) and in Romania. However, functional envelope clones of these subtypes are lacking, which are needed for studies on antibody-mediated neutralization, coreceptor usage, and efficiency of viral entry inhibitor drugs. Here we report the construction, neutralization properties, and coreceptor usage of HIV-1 functional envelope clones of subtypes G (n = 15) and F (n = 7). These clones were obtained through RT-PCR amplification of HIV-1 gp160 from plasma RNA, and were used for pseudovirus production. All 15 subtype G-enveloped pseudoviruses were resistant to neutralization by gp120-targeted broadly neutralizing monoclonal antibodies (MAbs) b12 and 2G12, while a majority were neutralized by gp41-targeted MAbs 2F5 and 4E10. With regard to the subtype F envelopes, all seven pseudoviruses were resistant to 2F5 and b12, six were resistant to G12, and six were neutralized by 4E10. Coreceptor usage testing revealed that 21 of 22 envelopes were CCR5-tropic, including all 15 subtype G envelopes, seven of which were from patients with CD4(+) T cell counts <200/ml. These results confirm the broadly neutralizing activity of 4E10 on envelope clones across all tested group M clades, including subtypes G and F, reveal the resistance of most subtype F-enveloped pseudoviruses to broadly neutralizing MAbs b12, 2G12, and 2F5, and suggest that, similarly to subtype C, CXCR4 tropism is uncommon in subtype G, even at advanced stages of infection.
Similar articles
-
HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry.AIDS. 2007 Mar 30;21(6):693-702. doi: 10.1097/QAD.0b013e32805e8727. AIDS. 2007. PMID: 17413690
-
HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.AIDS Res Hum Retroviruses. 2011 Aug;27(8):877-87. doi: 10.1089/AID.2010.0281. Epub 2011 Jan 19. AIDS Res Hum Retroviruses. 2011. PMID: 21158699 Free PMC article.
-
Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.AIDS Res Hum Retroviruses. 2011 Aug;27(8):863-76. doi: 10.1089/AID.2010.0265. Epub 2011 Jan 15. AIDS Res Hum Retroviruses. 2011. PMID: 21142698
-
Novel approaches for identification of broadly cross-reactive HIV-1 neutralizing human monoclonal antibodies and improvement of their potency.Curr Pharm Des. 2007;13(2):203-12. doi: 10.2174/138161207779313669. Curr Pharm Des. 2007. PMID: 17269928 Review.
-
HIV subtypes and recombination strains--strategies for induction of immune responses in man.Vaccine. 2002 May 6;20(15):1988-93. doi: 10.1016/s0264-410x(02)00084-1. Vaccine. 2002. PMID: 11983260 Review.
Cited by
-
Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications.J Virol. 2017 Sep 27;91(20):e00755-17. doi: 10.1128/JVI.00755-17. Print 2017 Oct 15. J Virol. 2017. PMID: 28768859 Free PMC article.
-
Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue.Retrovirology. 2012 Mar 15;9:20. doi: 10.1186/1742-4690-9-20. Retrovirology. 2012. PMID: 22420378 Free PMC article.
-
Short communication: Molecular epidemiology, phylogeny, and phylodynamics of CRF63_02A1, a recently originated HIV-1 circulating recombinant form spreading in Siberia.AIDS Res Hum Retroviruses. 2014 Sep;30(9):912-9. doi: 10.1089/AID.2014.0075. Epub 2014 Aug 14. AIDS Res Hum Retroviruses. 2014. PMID: 25050828 Free PMC article.
-
Construction and Characterization of HIV-1 env-Pseudoviruses of the Recombinant Form CRF63_02A and Subtype A6.Bull Exp Biol Med. 2022 Apr;172(6):729-733. doi: 10.1007/s10517-022-05466-7. Epub 2022 May 2. Bull Exp Biol Med. 2022. PMID: 35501651
-
Anti-HIV Activity of Snake Venom Phospholipase A2s: Updates for New Enzymes and Different Virus Strains.Int J Mol Sci. 2022 Jan 30;23(3):1610. doi: 10.3390/ijms23031610. Int J Mol Sci. 2022. PMID: 35163532 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous